鹽酸利度卡因全球市場成長、趨勢、預測（2020年∼2025年）

預估全球鹽酸利度卡因市場規模在預測期間中將以4.1％的CAGR成長。包含牙科手術、美容外科手術、整型手術等全球執行的外科手術數量增加，預估將推動該市場成長。全球慢性和急性疼痛病患增加、鹽酸利度卡因各項優點，是推動市場成長的主要因素。

市場上觀察到的主要趨勢是隨著外科手術增加，術後疼痛緩解選項的需求大幅增加。這項趨勢可能會持續正面影響鹽酸利度卡因的需求。 根據「術後疼痛管理」研究，約75％接受手術的病患會出現中度至重度的急性術後疼痛，這進一步推動整體成長。

此外，利度卡因貼片可治療慢性或急性疼痛。由於其經過驗證的安全性及有效性，利度卡因貼片被推薦為治療老年患者和帶狀泡疹相關神經性疼痛的第一選項療法，預估將在預測期間中推動市場成長。另一方面，特異體質或過敏性等副作用將阻礙市場成長。

本報告研究全球鹽酸利度卡因市場，綜合性彙整市場概要，提供按劑型、應用、區域的市場規模推移及預測，以及市場趨勢、市場成長及阻礙因素分析、市場機會、競爭情勢、主要企業簡介等情報。

目錄

第1章 前言

第2章 研究方法

第3章 摘要整理

第4章 市場動態

• 市場概要
• 市場成長因素
  • 標靶疾病的罹病率增加
  • 手術的麻醉藥需求增加
• 市場阻礙因素
  • 鹽酸利度卡因相關風險
• 波特五力分析

第5章 市場區分

• 按劑型
  • 霜劑
  • 貼劑
  • 注射劑
  • 其他
• 按應用
  • 心律不整
  • 牙科手術
  • 癲癇
  • 其他
• 按區域
  • 北美
  • 歐洲
  • 亞太地區
  • 中東及非洲地區
  • 南美

第6章 競爭情勢

• 企業簡介
  • Alanza Inc
  • Amphastar Pharmaceuticals, Inc.
  • Cirondrugs
  • MAHENDRA CHEMICALS
  • Medexim India
  • Merck KGaA
  • Nortec Qumica
  • Pfizer Inc

第7章 市場機會與未來趨勢

The lidocaine hydrochloride market size is expected to record a CAGR of 4.1% during the forecast period. An increase in the number of surgical procedures performed across the world, including dental procedures, cosmetic surgeries, and plastic surgeries, is expected to promote growth. The global rise in chronic and acute pain related disorders and various benefits associated with lidocaine hydrochloride are some of the major factors driving the market growth.

A key trend observed in the market is a significant rise in the demand for post-operative pain relief options, on the heels of an increasing number of surgical procedures. This trend is likely to continue to positively influence the demand for lidocaine hydrochloride. As per the study of "Postoperative Pain Control", around 75% of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity, which further bolsters the overall growth.

Also, lidocaine patches are available for the treatment of chronic and acute pain. Owing to their safety profile and proven efficacy, lidocaine patches have been recommended as a first-line therapy for the treatment of neuropathic pain in older patients, as well as those suffering from shingles, and this is expected to boost the market growth during the forecast period. However, side effects, such as idiosyncrasy and hypersensitivity, may restrict the market.

Key Market Trends

Dental Procedure Segment Dominates the Market and is Expected to Continue the Same during the Forecast Period

• The dental procedure segment is expected to record a lucrative CAGR during the forecast period. This is primarily attributed to the extensive usage of lidocaine hydrochloride injectable in different surgical dental procedures. An increase in the prevalence of dental disorders, coupled with the growing number of surgeries performed, is the key driving factor for this segment.
• Chronic and acute pain associated with dental procedures is the most common reason for visits to healthcare facilities, which makes it the foremost cause of discomfort in patients, thereby, contributing largely to healthcare costs. The aforementioned factors bode well for the segment's growth.

North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America is leading, owing to the presence of major market players. Increasing incidences of pain and pain-related disorders, coupled with the escalating prevalence of epilepsy and dental procedures in the United States, are among the factors driving the market in this region. This has been adding to the healthcare expenditures of the nations in the region. The incremental rise in the number of patients and increasing product cognizance and adoption have also been accelerating market growth in the region.

Asia-Pacific is expected to witness the fastest growth over the forecast period. The growth is attributed to the increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of lidocaine hydrochloride in post-operative pain management. Moreover, the expanding geriatric population is anticipated to drive the number of surgical procedures performed in the region, thereby promising growth over the forecast period.

Competitive Landscape

The lidocaine hydrochloride market is consolidated and consists of a selective number of major players. Some of the key players include companies, such as Alanza Inc, Amphastar Pharmaceuticals, Inc., Cirondrugs, Mahendra Chemicals, Medexim India, Merck KGaA, Nortec Qumica, and Pfizer Inc. Investment for the development of effective and long-acting products with lesser adverse effects and improving geographical penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market shares.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increase in Prevalence of Target Diseases
  • 4.2.2 Rising Demand for Anesthetics in Surgeries
• 4.3 Market Restraints
  • 4.3.1 Risk Associated with Lidocaine Hydrochloride
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Dosage Form
  • 5.1.1 Creams
  • 5.1.2 Patches
  • 5.1.3 Injectables
  • 5.1.4 Other Dosage Forms
• 5.2 By Application
  • 5.2.1 Heart Arrhythmia
  • 5.2.2 Dental Procedure
  • 5.2.3 Epilepsy
  • 5.2.4 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Alanza Inc
  • 6.1.2 Amphastar Pharmaceuticals Inc.
  • 6.1.3 Cirondrugs
  • 6.1.4 Mahendra Chemicals
  • 6.1.5 Medexim India
  • 6.1.6 Merck KGaA
  • 6.1.7 Nortec Qumica
  • 6.1.8 Pfizer Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS